SELF-REPORTED QUALITY OF LIFE IN COMPLEMENT 3 GLOMERULOPATHY PATIENTS DELINEATED BY CKD STAGE: A REAL-WORLD, MULTI-COUNTRY SURVEY

Back

E-Poster

Abstract Title

First Name *

Richard

Last Name *

Lafayette

Co-author 1

Raisa Sidhu raisa.sidhu@novartis.com Novartis Pharma AG HEOR Basel

Co-author 2

Clare Proudfoot clare.proudfoot@novartis.com Novartis Pharma AG HEOR Basel

Co-author 3

Katharina Pannagl katharina.pannagl@novartis.com Novartis Pharmaceuticals UK Ltd HEOR London

Co-author 4

Briana Ndife briana.ndife@novartis.com Novartis Pharmaceuticals Corporation HEOR New Jersey

Co-author 5

Serge Smeets serge.smeets@novartis.com Novartis Pharma AG HEOR Basel

Co-author 6

Kathleen Murphy kathleen_p.murphy@novartis.com Novartis Pharmaceuticals Corporation HEOR New Jersey

Co-author 7

Raymond Przybysz raymond.przybysz@novartis.com Novartis Pharmaceuticals Corporation HEOR New Jersey

Co-author 8

Jonathan de Courcy jonathan.decourcy@adelphigroup.com Adelphi Real World Rare Diseases Bollington

Co-author 9

Susanna Libby Susanna.Libby@adelphigroup.com Adelphi Real World Rare Diseases Bollington

Co-author 10

Smeeta Sinha smeeta.sinha@nca.nhs.uk NHS Renal Medicine Manchester

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15